NPI: 1154504892 · PLAINWELL, MI 49080 · Special Hospital · NPI assigned 12/17/2007
Authorized official HOUGHTON, MARINA controls 20+ related entities in our dataset. Read more
| Authorized Official | HOUGHTON, MARINA (CFO) |
| Parent Organization | BORGESS MEDICAL CENTER |
| NPI Enumeration Date | 12/17/2007 |
Other providers sharing the same authorized official: HOUGHTON, MARINA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,644 | $655K |
| 2019 | 16,508 | $630K |
| 2020 | 13,985 | $513K |
| 2021 | 18,585 | $702K |
| 2022 | 24,639 | $846K |
| 2023 | 24,016 | $902K |
| 2024 | 11,836 | $596K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,724 | 13,892 | $1.81M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,770 | 6,306 | $1.22M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,358 | 2,248 | $606K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,141 | 2,906 | $311K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,983 | 2,922 | $212K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4,429 | 1,280 | $97K |
| 71046 | Radiologic examination, chest; 2 views | 2,086 | 2,021 | $75K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 398 | 390 | $71K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,328 | 2,145 | $65K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 3,068 | 1,017 | $46K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,450 | 1,425 | $43K |
| 71045 | Radiologic examination, chest; single view | 757 | 743 | $33K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,172 | 4,037 | $31K |
| 80053 | Comprehensive metabolic panel | 9,713 | 9,066 | $28K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,967 | 1,919 | $27K |
| 96375 | Therapeutic injection; each additional sequential IV push | 811 | 755 | $22K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10,919 | 9,975 | $22K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 95 | 93 | $12K |
| 80061 | Lipid panel | 1,336 | 1,333 | $11K |
| 70450 | Computed tomography, head or brain; without contrast material | 116 | 115 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,917 | 1,867 | $9K |
| 97162 | 143 | 138 | $6K | |
| 83718 | 1,620 | 1,596 | $5K | |
| 36415 | Collection of venous blood by venipuncture | 8,786 | 7,903 | $5K |
| 82728 | 758 | 729 | $5K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,364 | 2,192 | $5K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 122 | 120 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,720 | 1,604 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 37 | 36 | $4K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 146 | 94 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 67 | 67 | $3K |
| 84478 | 1,341 | 1,312 | $3K | |
| 82465 | 1,632 | 1,602 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 162 | 156 | $2K |
| 81001 | 5,807 | 5,486 | $2K | |
| 73630 | 247 | 243 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,758 | 1,680 | $2K |
| 73610 | 193 | 189 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 48 | 45 | $1K |
| 73562 | 123 | 119 | $1K | |
| 85027 | 507 | 479 | $1K | |
| 82607 | 178 | 177 | $1K | |
| 83690 | 2,024 | 1,862 | $1K | |
| 84439 | 201 | 198 | $955.91 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 143 | 142 | $949.74 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 143 | 142 | $949.74 |
| 83540 | 316 | 305 | $945.77 | |
| 83735 | 465 | 426 | $908.08 | |
| 74018 | 24 | 24 | $897.74 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 201 | 194 | $869.34 |
| 73030 | 51 | 51 | $832.19 | |
| 84703 | 2,719 | 2,595 | $799.44 | |
| 73130 | 97 | 93 | $779.65 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13 | 13 | $764.05 |
| 84484 | 1,271 | 1,134 | $737.69 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 12 | 12 | $722.96 |
| 85610 | 444 | 367 | $623.08 | |
| 83550 | 119 | 115 | $584.66 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 368 | 332 | $510.96 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 974 | 539 | $505.17 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 39 | 39 | $478.15 |
| 85651 | 273 | 251 | $464.46 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 351 | 348 | $349.67 |
| 87186 | 268 | 263 | $342.03 | |
| 82043 | 116 | 116 | $324.80 | |
| 83605 | 221 | 201 | $304.77 | |
| 73110 | 27 | 27 | $293.66 | |
| 86140 | 121 | 115 | $273.89 | |
| 87254 | 118 | 80 | $267.46 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 26 | 26 | $264.65 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,711 | 2,495 | $235.72 |
| 87486 | 12 | 12 | $231.46 | |
| 87581 | 12 | 12 | $231.46 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 12 | 12 | $231.46 |
| 84702 | 36 | 24 | $219.29 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,100 | 1,086 | $201.14 |
| 87430 | 864 | 856 | $196.11 | |
| 72100 | 12 | 12 | $178.92 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 13 | 13 | $173.33 |
| 87077 | 48 | 47 | $94.17 | |
| 83880 | 16 | 14 | $78.50 | |
| 85730 | 38 | 38 | $65.86 | |
| 86592 | 39 | 39 | $55.12 | |
| 86703 | 38 | 38 | $51.66 | |
| 85379 | 48 | 48 | $48.01 | |
| 87634 | 168 | 161 | $46.24 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,472 | 3,245 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 498 | 486 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 133 | 120 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 42 | 40 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 30 | 30 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,660 | 2,458 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,119 | 1,077 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,552 | 1,467 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 78 | 68 | $0.00 |
| 87420 | 20 | 20 | $0.00 |